-
Certara Acquires Analytica Laser, a Leader in Market Access, Health Economics and Outcomes Research (HEOR), and Real-world Evidence Solutions
Apr 12, 2018, 16:57 PM by Michael CroftPRINCETON, NJ - Apr 12, 2018 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has acquired Analytica Laser, a global research consultancy that uses health economics and outcomes research (HEOR) and real-world data to provide the highest level of scientific evidence of the value of medicines and health technologiesFull story -
BioIVT to Discuss Best Practices for Assessing T Cell-mediated Cytotoxicity at the AACR Annual Meeting
Apr 12, 2018, 11:22 AM by Michael CroftWESTBURY, NY - Apr 12, 2018 - BioIVT, a leading provider of biospecimens and related services, today announced that it will be focusing on best practices for assessing T cell-mediated cytotoxicity at the American Association for Cancer Research (AACR) Annual MeetingFull story -
BC Platforms Appoints Richard Kivel as Chairman to Accelerate Global Growth
Apr 12, 2018, 03:26 AM by Michael CroftBASEL, BOSTON, SWITZERLAND - Apr 12, 2018 - BC Platforms, a world leader in genomic data management and analytics, today announces that it has appointed Richard Kivel as its ChairmanFull story -
Genomics England uses MongoDB to Power the Data Science Behind the 100,000 Genomes Project
Apr 11, 2018, 16:07 PM by Michael CroftNYC, NY, UNITED STATES - Apr 10, 2018 - Genomics England is using MongoDB, the leading modern, general purpose data platform, to power the data science that makes the 100,000 Genomes Project possible and reduce the processing time for complex queries from hours to milliseconds, enabling scientists to discover new insights, fasterFull story -
HudsonAlpha’s Genomic Medicine Conference: Embracing A Brave New World
Apr 11, 2018, 10:40 AM by Michael CroftFull storyBio-IT World | Coinciding with the Institute’s 10-year anniversary, HudsonAlpha hosted their second Genomic Medicine Conference this week on their campus in Huntsville, Ala. For two and a half days researchers, geneticists and healthcare professionals told their stories about how genomic data has impacted their respective professions and how the data they have been collecting influences their patients.
-
The RSA Group Strengthens Commitment to Swiss Life Sciences
Apr 11, 2018, 04:56 AM by Michael CroftLONDON, UK - Apr 11, 2018 - The RSA Group, a leading Life Sciences executive search firm, is increasing its commitment to serving clients based in SwitzerlandFull story -
PerkinElmer Collaborates With Helix To Drive Innovation In Exome-Based Personal Genomics
Apr 10, 2018, 11:15 AM by Michael CroftFull storyBio-IT World Brief | PerkinElmer has announced a collaboration with Helix to develop and commercialize exome sequencing-based tests that will empower consumers to make proactive health management decisions. Tests developed as part of this collaboration will be available to customers of Helix’s expanding online marketplace for DNA-powered products.
-
Almac Discovery to Present at American Association for Cancer Research 2018
Apr 10, 2018, 08:31 AM by Michael CroftCRAIGAVON, N.I., UK - Apr 10, 2018 - Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, is pleased to announce it will present 2 posters during this years AACR Annual Meeting 2018 in Chicago, April 14-18Full story -
CloudLIMS’ New Client Portal Enhances Customer Service Capabilities of Biobanks & Testing Laboratories
Apr 10, 2018, 04:45 AM by Michael CroftWILMINGTON, US - Apr 10, 2018 - CloudLIMS, a leading laboratory data management informatics provider, announces the release of a web-based client portal for its Laboratory Information Management System (LIMS), CloudLIMSFull story -
Dam Data: Health Systems, Machines, And Learning
Apr 9, 2018, 14:55 PM by Michael CroftFull storyBio-IT World Contributed Commentary | Increased use of electronic health records and other digital data has brought what amounts to a deluge of potential evidence, one that never ends. A “learning health system” can create the equivalent of a hydroelectric dam – a place to catch all of those raindrops in one place and release them in a coordinated, powerful way.
-
Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: A Journey To Focus On Data And Digital
Apr 9, 2018, 11:49 AM by Michael CroftForbes | Novartis announced it would buy gene therapy pioneer AveXis for $8.7 billion, giving the Swiss drug giant several treatments for rare diseases that work by inserting new DNA into patients' cells.Full story -
ChargePoint Technology boosts US team to support regional growth
Apr 9, 2018, 11:36 AM by Michael Croft, N/A, UNITED STATES - Apr 9, 2018 - Powder containment and aseptic transfer valve specialist ChargePoint Technology, has appointed two new area managers to support the increased demand for its containment technologies and solutions throughout the USFull story -
Equus VP of Customer Solutions to Deliver a Keynote Address at IDeACOM 2018
Apr 6, 2018, 12:46 PM by Michael CroftEDINA, MN, UNITED STATES - Apr 6, 2018 - Equus Compute Solutions, the largest U.S. manufacturer of custom computer hardware systems to the channel, announces its Vice President of Customer Solutions Steve Grady will deliver a keynote address at IDeACOM 2018, taking place April 8-10 in Washington, DFull story -
This Company Can Encode Your Favorite Song In DNA—For $100,000
Apr 6, 2018, 11:04 AM by Michael CroftMIT Technology Review | It's not cheap. But Twist Bioscience thinks storing data in genes could be the next big thing.Full story -
First Annual Model-informed Drug Development Gran Prix Deemed a Success
Apr 5, 2018, 14:18 PM by Michael CroftPRINCETON, NJ - Apr 5, 2018 - Certara®, the global leader in model-informed drug development and regulatory science, and faculty at the UNC Eshelman School of Pharmacy today announced the winners of the first Model-informed Drug Development (MIDD) Gran PrixFull story -
Five Use Cases For AI and Machine Learning In Commercial Pharma
Apr 4, 2018, 09:00 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Over the last decade, early business uses of Artificial Intelligence (AI), or machine learning, in life sciences have proven successful in drug discovery – predicting molecule-target bonding, identifying new biomarkers, and uncovering new drug indications. Now machine learning is gaining broader traction into other areas, including commercial operations, and transforming the way the industry collects, synthesizes, and uses data.
-
Sekisui XenoTech Adds Fatty Liver Disease Tissue Arrays, Microsome Pool to Research Biobank
Apr 3, 2018, 09:41 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - Apr 3, 2018 - Sekisui XenoTech now offers human liver tissue microarrays and a microsomal pool for studying and developing new treatments for fatty liver disease (FLD)Full story -
Kite Pharma Veterans Launching New Firm To Develop Off-The-Shelf CAR-T
Apr 3, 2018, 08:45 AM by Michael CroftSTAT | Two former Kite Pharma executives unveiled Allogene Therapeutics, a new company trying to develop a suite of CAR-T therapy assets designed so that they do not need to be personalized for each cancer patient.Full story -
Platypus: Deep Data Dives For Clinical Data Reviewer
Apr 2, 2018, 09:05 AM by Michael CroftFull storyBio-IT World | If you are creating a tool designed to give a sixth sense, of course you name it after a semiaquatic, egg-laying mammal endemic to eastern Australia. Not unlike the animal, Takeda’s Platypus is made up of various parts, specifically designed to meet the medical reviewer’s needs.
-
Neurocentrx appoints two industry heavyweights to Board
Apr 2, 2018, 05:17 AM by Michael Croft- Apr 2, 2018 - Neurocentrx, an Edinburgh-based pharmaceutical company, has appointed Nigel Brooksby as Non-Executive Chairman and DrFull story